Anavex Life Sciences Corp. (NASDAQ: AVXL)
| Pre-Market |
Intra-Day |
After-Hours |
| - (- / -%) |
3.65 (0.01 / 0.27%) |
3.73 (0.08 / 2.19%) |
| - |
20-Apr 16:00 |
20-Apr 18:50 |
Sector:
Healthcare || Industry:
Biotechnology
| Previous Close |
3.64 |
Year Low |
2.61 |
| Open |
3.57 |
Year High |
13.99 |
| Day Low |
3.54 |
Price Avg 50 |
3.91 |
| Day High |
3.76 |
Price Avg 200 |
6.67 |
| Volume |
1.1 M |
Market Cap |
338.25 M |
News
Analysis
| AVXL |
0.27 |
15.87 |
-10.10 |
-27.44 |
-61.00 |
-58.33 |
Earnings
| 02/09/2026 |
BMO |
AVXL |
Anavex Life Sciences |
Q1 2026 |
EPS |
-0.11 |
-0.06 |
45.45 |
-0.14 |
57.10 |
|
| 02/09/2026 |
BMO |
AVXL |
Anavex Life Sciences |
Q1 2026 |
REV |
|
|
0.00 |
|
0.00 |
|
| 11/25/2025 |
BMO |
AVXL |
Anavex Life Sciences |
Q4 2025 |
EPS |
-0.15 |
-0.11 |
26.67 |
-0.14 |
21.40 |
|
| 11/25/2025 |
BMO |
AVXL |
Anavex Life Sciences |
Q4 2025 |
REV |
|
|
|
|
|
|
| 08/12/2025 |
BMO |
AVXL |
Anavex Life Sciences |
Q3 2025 |
EPS |
-0.14 |
-0.16 |
-14.29 |
-0.14 |
-14.30 |
|
| 08/12/2025 |
BMO |
AVXL |
Anavex Life Sciences |
Q3 2025 |
REV |
|
|
0.00 |
|
0.00 |
|
| 05/13/2025 |
BMO |
AVXL |
Anavex Life Sciences |
Q2 2025 |
EPS |
-0.15 |
-0.13 |
13.33 |
-0.13 |
|
Healthcare / Biotechnology |
| 05/13/2025 |
BMO |
AVXL |
Anavex Life Sciences |
Q2 2025 |
REV |
|
|
0.00 |
|
0.00 |
Healthcare / Biotechnology |
Outlooks
* Growth at Outlook Mid-point against Estimate
Ratings
| 03/31/2026 |
AVXL |
D. Boral Capital |
Buy |
Buy |
Maintain |
| 03/26/2026 |
AVXL |
D. Boral Capital |
Buy |
Buy |
Maintain |
| 03/23/2026 |
AVXL |
D. Boral Capital |
Buy |
Buy |
Maintain |
| 02/10/2026 |
AVXL |
HC Wainwright & Co. |
Buy |
Buy |
Maintain |
| 02/09/2026 |
AVXL |
D. Boral Capital |
Buy |
Buy |
Maintain |
| 01/06/2026 |
AVXL |
D. Boral Capital |
Buy |
Buy |
Maintain |
Dividends
Sign-Up to see the full list of CATALYSTS in the Calendars
<<Back to Stock Screener>>
